Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
finasteride, Quantity: 5 mg
Alphapharm Pty Ltd
Finasteride
Tablet, film coated
Excipient Ingredients: magnesium stearate; pregelatinised maize starch; microcrystalline cellulose; lactose monohydrate; docusate sodium; sodium starch glycollate type A; titanium dioxide; indigo carmine aluminium lake; hypromellose; macrogol 400
Oral
28 tablets, 30 Tablets
(S4) Prescription Only Medicine
Treatment of patients with symptomatic benign prostatic hyperplasia (BPH) with an enlarged prostate.
Visual Identification: Blue coloured, oval shaped, biconvex, film-coated tablet, debossed with 'FIN' on one side and '5' on the other side; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius
Registered
2010-06-18
FINIDE _Finasteride_ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about FINIDE. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking FINIDE against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT FINIDE IS USED FOR FINIDE is for use by men only. FINIDE is used to treat a medical condition in men called benign prostatic hyperplasia or BPH. BPH is a condition where your prostate gland (which is near your bladder) has become bigger making it more difficult for you to pass urine. This can lead to symptoms such as: • weak or interrupted stream of urine • feeling that you cannot empty your bladder completely • delay before you start to pass urine • needing to pass urine often, especially at night • feeling that you must pass urine right away BPH occurs only in men and is common over the age of 50 years. In some men, BPH can lead to serious problems, including urinary tract infections and the sudden inability to pass urine at all. BPH can also lead to the need for surgery such as procedures to improve the flow of urine. The prostate gland takes years to grow. Therefore, the symptoms of BPH take a long time to develop. FINIDE works by slowly reducing the size of your prostate gland. This may lead to gradual improvement in your urine flow and other symptoms over several months. FINIDE also helps reduce the risk of developing a sudden inability to pass urine (acute urinary retention) and the need for surgery. This may happen whether or not you notice any improvement or change in your symptoms. Your doctor may have prescribed FINIDE for another reason. Ask your doctor if you have any questions about why FINIDE has been prescribed for you. FINIDE is not addicti Read the complete document
AUSTRALIAN PRODUCT INFORMATION FINIDE _Finasteride film coated tablet _ 1 NAME OF THE MEDICINE Finasteride 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Finide film coated tablets contain 5 mg of finasteride as the active ingredient. Excipients with known effect: Lactose monohydrate. For the full list of excipients, see Section 6.1 LIST OF EXCIPIENTS . 3 PHARMACEUTICAL FORM Finide 5 mg tablets are blue colored, oval shaped, biconvex, film-coated tablets, debossed with ‘FIN’ on one side and ‘5’ on the other side. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment of patients with symptomatic benign prostatic hyperplasia (BPH) with an enlarged prostate. 4.2 DOSE AND METHOD OF ADMINISTRATION The recommended dosage is one 5 mg tablet daily with or without food. DOSAGE IN IMPAIRED RENAL FUNCTION Adjustments in dosage are not necessary in patients with varying degrees of renal insufficiency (creatinine clearances as low as 9 mL/minute) as pharmacokinetic studies did not indicate any change in the disposition of finasteride. DOSAGE IN THE ELDERLY No adjustment in dosage is required although pharmacokinetic studies indicated that the elimination of finasteride is somewhat decreased in patients aged over 70 years. 4.3 CONTRAINDICATIONS Finide is contraindicated in the following: • Use in women when they are or may potentially be pregnant (see Section 4.6 FERTILITY, PREGNANCY AND LACTATION, USE IN PREGNANCY, EXPOSURE TO FINASTERIDE, RISK TO A MALE FOETUS , and Section 6.4 SPECIAL PRECAUTIONS FOR STORAGE ). • Hypersensitivity to any component of this product. • Use in women or children. Finide – PRODUCT INFORMATION 2 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE GENERAL Since the beneficial response to finasteride may not be manifested immediately, patients with large residual urine volume and/or severely diminished urinary flow should be carefully monitored for obstructive uropathy. Finasteride may not reduce inconvenience to patients arising from benign prostatic hyperplasia (BPH) symptoms in patient Read the complete document